当前位置:主页 > 医学论文 > 传染病论文 >

头孢曲松钠联合胸腺五肽治疗早期宫颈癌合并梅毒的疗效观察

发布时间:2018-04-19 02:06

  本文选题:头孢曲松钠 + 胸腺五肽 ; 参考:《中国地方病防治杂志》2017年03期


【摘要】:目的分析头孢曲松钠联合胸腺五肽治疗早期宫颈癌合并梅毒的效果。方法 100例早期宫颈癌合并梅毒患者按治疗方案不同用双盲法分为对照组(青霉素钠联合苄星青霉素)和观察组(头孢曲松钠联合胸腺五肽)。记录治疗1周患者皮损消退率,治疗前及治疗2周后血清T细胞水平;以12、24、48周为时间点对比两组快速血浆反应素环状卡片实验(RPR)转阴率、梅毒复发率、梅毒治疗有效率;记录0.5、1年生存率。结果 1周时观察组皮损消率高于对照组;治疗2周时CD4+和CD3+高于对照组,CD8+低于对照组;12、24、18周RPR转阴率均高于对照组,梅毒复发3例低于对照组,梅毒治疗有效率高于对照组;1年生存率高于对照组(P均0.05)。结论头孢曲松钠联合胸腺五肽治疗早期宫颈癌合并梅毒能快速消退皮损,改善T细胞水平,近期能提高RPR转阴率,降低梅毒复发率,能提高1年生存率。
[Abstract]:Objective to analyze the effect of ceftriaxone sodium combined with thymic pentapeptide in the treatment of early cervical cancer with syphilis.Methods 100 patients with early cervical cancer complicated with syphilis were divided into two groups: control group (penicillin sodium combined with benzylpenicillin) and observation group (ceftriaxone sodium combined with thymopeptide).The regression rate of skin lesion, the serum T cell level before treatment and 2 weeks after treatment were recorded, and the rapid plasma RPR-negative rate, the recurrence rate of syphilis and the effective rate of syphilis treatment were compared between the two groups.The 0.5 and 1 year survival rates were recorded.Results the skin lesion elimination rate in the observation group was higher than that in the control group at 1 week, the CD4 and CD3 were higher in the observation group than in the control group at 2 weeks after treatment, and the RPR negative rate in the control group at 18 weeks was lower than that in the control group.The effective rate of syphilis treatment was higher than that of control group, and the 1 year survival rate was higher than that of control group (P < 0.05).Conclusion Ceftriaxone sodium combined with thymic pentapeptide in the treatment of early cervical cancer with syphilis can quickly dissipate lesions, improve T cell level, increase RPR negative rate, reduce syphilis recurrence rate and improve 1 year survival rate in the near future.
【作者单位】: 鄂尔多斯妇产医院;鄂尔多斯市干部保健中心;
【基金】:深圳市医学科研项目(编号:200603116)
【分类号】:R737.33;R759.1

【相似文献】

相关期刊论文 前10条

1 张丰林;;胸腺五肽治疗恶性肿瘤患者的免疫指标初探[J];传染病信息;2000年01期

2 张绪清,王宇明,毛青,向德栋,马巧玉;胸腺五肽治疗慢性重型乙型病毒性肝炎的疗效评价[J];第三军医大学学报;2003年22期

3 周红华,马仁玲,黄海燕,濮社班,盛龙生;胸腺五肽一级结构的电喷雾质谱分析[J];西北药学杂志;2004年06期

4 钟晖东;李斌;陈伟强;;胸腺五肽对老年重型脑损害病人T淋巴细胞亚群的影响[J];广东微量元素科学;2006年06期

5 金j;魏刚;陆伟跃;;胸腺五肽溶液稳定性考察[J];中国医药工业杂志;2007年10期

6 艾国;梅兴国;;胸腺五肽微球体外释放度的加速试验方法研究(英文)[J];Journal of Chinese Pharmaceutical Sciences;2008年01期

7 陈君;庞杰;张春彦;许楠;;胸腺五肽配合治疗慢性阻肺38例疗效观察[J];中国民族民间医药;2009年02期

8 郑爱萍;王坚成;张p,

本文编号:1771082


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/1771082.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户b2a71***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com